- Home
- FTRE vs ADNT Comparison
FTRE vs ADNT Comparison
Compare FTRE & ADNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTRE
- ADNT
- Stock Information
- Founded
- FTRE 1996
- ADNT 2016
- Country
- FTRE United States
- ADNT Ireland
- Employees
- FTRE N/A
- ADNT N/A
- Industry
- FTRE Medical Specialities
- ADNT Auto Parts:O.E.M.
- Sector
- FTRE Health Care
- ADNT Consumer Discretionary
- Exchange
- FTRE Nasdaq
- ADNT Nasdaq
- Market Cap
- FTRE 469.0M
- ADNT 921.6M
- IPO Year
- FTRE N/A
- ADNT N/A
- Fundamental
- Price
- FTRE $5.95
- ADNT $13.79
- Analyst Decision
- FTRE Hold
- ADNT Hold
- Analyst Count
- FTRE 11
- ADNT 10
- Target Price
- FTRE $18.00
- ADNT $18.00
- AVG Volume (30 Days)
- FTRE 2.3M
- ADNT 1.2M
- Earning Date
- FTRE 05-12-2025
- ADNT 05-07-2025
- Dividend Yield
- FTRE N/A
- ADNT N/A
- EPS Growth
- FTRE N/A
- ADNT N/A
- EPS
- FTRE N/A
- ADNT N/A
- Revenue
- FTRE $2,696,400,000.00
- ADNT $14,384,000,000.00
- Revenue This Year
- FTRE N/A
- ADNT N/A
- Revenue Next Year
- FTRE $3.32
- ADNT $0.83
- P/E Ratio
- FTRE N/A
- ADNT N/A
- Revenue Growth
- FTRE N/A
- ADNT N/A
- 52 Week Low
- FTRE $4.77
- ADNT $10.04
- 52 Week High
- FTRE $37.24
- ADNT $31.19
- Technical
- Relative Strength Index (RSI)
- FTRE 43.28
- ADNT 61.84
- Support Level
- FTRE $5.40
- ADNT $11.89
- Resistance Level
- FTRE $6.38
- ADNT $13.07
- Average True Range (ATR)
- FTRE 0.45
- ADNT 0.58
- MACD
- FTRE 0.21
- ADNT 0.23
- Stochastic Oscillator
- FTRE 72.52
- ADNT 94.68
About FTRE Fortrea Holdings Inc.
Fortrea Holdings is a late-stage contract research organization, or CRO, that provides comprehensive Phase I through IV clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.
About ADNT Adient plc
Adient began trading Oct. 31, 2016, when Johnson Controls spun off its automotive experience segment. Adient is the leading seating supplier to the industry with about one third of the global market. Its share in China is now nearly 20%, down from about 45%, following the sale of its main joint venture there at the end of fiscal 2021. Unconsolidated revenue from joint ventures was about $3.8 billion in fiscal 2024 and consolidated China revenue was $1.4 billion. The company is headquartered in Ireland but has corporate offices in the Detroit area. Fiscal 2024 (Sept. 30 year-end) consolidated revenue, which excludes joint venture sales, was $14.7 billion.